Sandoz Delivers On Promise Of US Natalizumab Launch

Tyruko Biosimilar To Tysabri Had Been Delayed By JCV Assay

 
• By Dave Wallace
  
Sandoz has launched Tyruko in the US (Shutterstock)

More from Biosimilars

More from Products